Navigation Links
Researchers determine risk factors for infection after liver transplantation
Date:6/5/2008

Nearly 9 percent of patients who recently underwent liver transplantation suffered a subsequent surgical site infection (SSI). Risk factors included having had biliary-enteric anastomosis (choledocho-jejunal or hepatic-jejunal reconstruction), previous liver or kidney transplant, and more than four red blood cell units transfused. These findings are published in the June issue of Liver Transplantation, a journal by John Wiley & Sons. The article is also available online at Wiley Interscience (www.interscience.wiley.com).

SSIs are common after liver transplantation and are a major cause of morbidity and mortality. They result from the technical complexity of the procedure, the fact that it occurs within a potentially infected area of the body and the poor medical condition of many recipients. Researchers aimed to determine the incidence, timing, location and risk factors, including antibiotic prophylaxis, for such infections.

They designed a prospective study that included 1,222 consecutive patients who received liver transplants in 11 Spanish hospitals between August 2003 and September 2005. They included all infections that developed up to six months after surgery, including both wound incisional and organ/space infection, hepatic and intra-abdominal abscess, and peritonitis. To assess risk factors for surgical site infections, they looked at patients who became ill in the first 30 days after their surgery. They then examined possible risk factors for their infections.

SSIs occurred in 8.8 percent of patients, most within the first few weeks after the transplant. About 10 percent of these were fatal, which is a great improvement over the past. The predominant infection site was the incision (42 percent) while 39 percent of infections were peritonitis; 16 percent intraabdominal abscess and 10 percent hepatic abscess.

Most infections were caused by gram-negative aerobic bacter
'/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers ID Inflammation-Fighting Pathway in Fat Cells
2. Virginia Tech researchers find human virus in chimpanzees
3. Brown researchers work toward ending cartilage loss
4. NARSAD researchers identify specific genes and family traits linked to mental illnesses
5. Researchers identify proteins making up mechanosensitive ion channels
6. OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
7. UNC health researchers explore how to take interactive video games to the next level
8. OHSU Cancer Instutute researchers find abnormalities in gene for melanoma
9. Penn researchers gain new insights on spinal muscular atrophy
10. OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy
11. Researchers Develop Stem Line With Sickle Cell Mutation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... COLUMBIA, S.C., Nov. 21 /PRNewswire-USNewswire/ -...mmittee for Quality Assurance (NCQA) ranked BlueCh...ird of America,s Best Health Plans(TM), published ... , , The respected annual ranking ranks the...ity, member satisfaction and NCQA accreditation sc...
(Date:11/21/2008)... FRANKLIN LAKES, N.J., Nov. 21 /PRNewswire-FirstCa...ice for medical intervention in treating 88 percen...0 percent of Americans treated for a chronic condi...ug spending and 75 percent of all medical costs. ...ree years by Medco Health Solutions, Inc. (NYSE: ...
(Date:11/21/2008)... Study found 2 popular drugs do not cause genetic ...AY, Nov. 21 (HealthDay News) -- Two popular medica... disorder (ADHD) do not cause genetic damage linke...w study says. , The study, done by researchers ... Institutes of Health, counters a previous one tha...
(Date:11/21/2008)..., In 430 B.C., a new and deadly diseaseits cause ...ek city-state was teeming with citizens, soldiers ... and Sparta. As streets filled with corpses, socia... illness returned twice and Athens lost a third of...f Athens marked the beginning of the end of the Go...
Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...ialists at UT Southwestern Medical Center have fou...d bacteria// that cause some of the most common ac...chers have looked for clues to an infection by tra...ing it. But that doesn’t always work because the b...
...outhern Indian state of Tamilnadu has launched a f...ients. The World Food Programme of the United Na...te government in running this scheme called Nutrip...n, Country Director for UNWFP and V.K.Subburaj, He...
...roposes to set up quality hospitals on the model o... Delhi, in Patna//, Raipur, Bhopal, Bhubaneshwar, ...stha Sureksha Yojna (PMSSY), Union Minister for He...doss has said. In a written reply to questions ra...
...d of India (AWBI) has started a pilot project in c...a new anti-rabies// oral bait vaccine that will be...and community dogs are being sterilized in India, ...mmunity dog population in the country is estimated...
Other Medicine News:Health News:‘Fingerprints’ to Track Common Infections in Childr 2Health News:‘Fingerprints’ to Track Common Infections in Childr 3
(Date:11/19/2008)...RANCISCO, Nov. 19 Posit Science Co...nce at the Society for Neuroscience,Annual Confer...ognitive,training may benefit Baby Boomers. The ... Program (TM) uses adaptive exercises that target ... designed to drive generalized,improvements in co...
(Date:11/19/2008)... , Study did not achieve statistical significa...FirstCall/ -- Pharmos Corporation (Nasdaq: PARS ...al trial of its topical NanoEmulsion (NE) drug del...thanolamine. , , The multi-center, randomiz...ated the safety and efficacy of the Company,s 3% D...
(Date:11/19/2008)...OCHELLE, N.Y., Nov. 19 Biotech sci...ogies to toxicology research to better understand ...of organ systems, reports Genetic Engineering &am...y interested in figuring out a new compound,s mech...tive toxicology technique, according to the Novemb...
(Date:11/19/2008)...gers $5 Million Payment from Roche- , , MON...ory Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... for its Phase 2 trial of R3487/MEM 3454, its lead...impairment associated with schizophrenia (CIAS). ...se 2 trial, triggering a $5.0 million payment from...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System 724 1Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System 724 2Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System 724 3Researchers discover new way to predict survival in older women with lung cancer 5267 1Researchers discover new way to predict survival in older women with lung cancer 5267 2Researchers discover new way to predict survival in older women with lung cancer 5267 3No racial differences seen in outcomes after liver transplantation 5265 1No racial differences seen in outcomes after liver transplantation 5265 2Potential new therapeutic molecular target to fight cancer 1076 1Potential new therapeutic molecular target to fight cancer 1076 2
...n Cancer Treatment,Decisions , SALT LAKE CITY, UT,...GN) (<a target="_blank" href=,"http://www.myriad.c...ented studies for a new technology that might be u...atic tumor, on Monday,April 16, 2007 at the annua...esearch (AACR) in Los Angeles, California. This wo...
..., Switzerland, April 19, 2007 /PRNewswire/ -- Debi...opharmaceutical,development specialist in oncology...nal results of a previous phase Ib, 15 day study,w...CV (hepatitis C,virus) co-infected patients. The d...he European Association for the Study of the,Liver...
Other Medicine Technology:Myriad Genetics Presents Tumor Origin Technology at AACR 2Myriad Genetics Presents Tumor Origin Technology at AACR 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 2Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 4
DrDrugs®: Drug Guide for Physicians - now with over 760 Integrated Calculators - combines the most comprehensive, up-to-date and practical drug resource with built in drug dosing calculation too
Clinician's Pocket Drug Reference 2005 includes key elements of commonly used medications that are essential information for both the student and practicing physician.
The pharmaceutical subset of the authoritative 2005 edition of Title 21 of the Code of Federal Regulations (CFR) with proposals and final rules published in the Federal Register. Content is updated r
The Quality Module QS I evaluates and classifies the quality and quantity of centrifuged serum samples. The System analyses the tube, volume and cap and recognizes if a sample contains hemolytic, lip
Medicine Products: